PowerShares Dynamic Pharmaceuticals Portfolio (PJP)

  • Loading...
#10

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 14 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Typical
Tracking Error Good
Bid/Ask Ratio Good
Holdings Diversity Typical

Fund Description

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Pharmaceuticals IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. pharmaceuticals companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. It is non-diversified.

Fund Snapshot Updated 07.21.2014

Previous Close $59.89 Expense Ratio 0.60%
YTD Return 12.28% Avg. 30-Day Volume 125,121
1-Year Return 32.0% Market Cap Loading...
Bid $59.89 Shares Outstanding 19,250,000
Ask $59.91 Dividends $0.25
Top 10 Holdings
Gilead Sciences Inc (GILD) 5.57%
Lilly Eli & Co (LLY) 5.41%
Amgen Inc (AMGN) 5.23%
Pfizer Inc (PFE) 5.22%
Merck & Co Inc New (MRK) 5.10%
Johnson & Johnson (JNJ) 5.08%
Bristol Myers Squibb Co (BMY) 5.01%
Biogen Idec Inc (BIIB) 4.83%
Akorn Inc (AKRX) 3.54%
Salix Pharmaceuticals Inc (SLXP) 3.32%
% of Total Holdings 48.30%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds